first semaglutide injection Canada approves generic from Dr. Reddy's, a G7 enabled by Novo Nordisk's lapsed CAD$250 patent FDA Approves Oral Semaglutide: First

Clinical trials have elucidated that CIT supplementation enhances endothelial functionality, muscle oxygenation, and exercise performance among older adults (86, 87)

Section 2: Diagnosis of type 1 diabetes Adults with new-onset type 1 diabetes can present with a short duration of illness of 14 weeks or a more slowly evolving process that can be mistaken for type 2 diabetes

Tro Kalayjian, DO Obesity medicine physician, founder of Dr

Coverage remains inconsistent across commercial plans and is excluded from most Medicare Part D formularies for obesity indications as of 2026

Sleep apnea, hypothyroidism, polycystic ovary syndrome, and other metabolic conditions all interact with weight regulation